Department of Rehabilitation Sciences, Ghent University (Hospital)
Ghent, East-Flanders, 9000, Belgium
NCT Number: NCT06137131
1. The first objective of this research is to investigate the immediate effects of three semi-occluded vocal tract (SOVT) exercises (straw phonation in air, straw phonation in 2cm water, and straw phonation in 5cm water) on (supra)glottic activity of vocally healthy participants and patients with voice disorders (dysphonia) visualized with laryngovideostroboscopy.
Participants will receive a flexible laryngovideostroboscopy, both during normal phonation and during the specific SOVT exercise. These videos will be randomly and blindly evaluated by two experts using the Voice-Vibratory Assessment with Laryngeal Imaging (VALI) rating form (Poburka et al., 2017).
Researchers will compare the effects of these SOVT exercises on the (supra)glottic activity with the effects found in a control group producing /u/ phonation, using a randomized controlled trial. 2. The second objective of this research is to investigate the short- and long-term effects of the three SOVT therapy approaches on the (supra)glottic activity, voice quality and self-report of patients with voice disorders (dysphonia).
Participants will receive a short-term intensive therapy with the specific SOVT exercise across four weeks.
Immediately after the therapy program and at 1 and 3 months follow-up, the voice of the participants will be re-evaluated.
Looking for future studies?
Notify Me17 year–50 year
All sexes
Interventional
Not applicable
Ghent, East-Flanders, 9000, Belgium
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Patients:
Inclusion criteria
are aged between 17 and 50 years, and diagnosed with dysphonia by an otorhinolaryngologist and SLP experienced in voice diagnostics. Exclusion criteria are previous or current participation in voice therapy, previous phonosurgical interventions, pregnancy, smoking, nasal or ear diseases, and neurological disorders.
Vocally healthy participants:
Inclusion criteria
are aged between 17 and 50 years. Exclusion criteria are dagnosed with dysphonia, previous or current participation in voice therapy, previous phonosurgical interventions, pregnancy, smoking, nasal or ear diseases, and neurological disorders.
Phonation (/u/ vowel) through a stirring straw (3 mm diameter, 20cm length) in air
Other names: steady SOVT exercise
Phonation (/u/ vowel) through a stirring straw (3 mm diameter, 20cm length) in 2 cm or 5 cm water
Other names: water-resistance therapy, fluctuating SOVT exercise
/u/ phonation without a straw, control condition
Other names: articulatory/steady SOVT exercise
Time frame: baseline (before the intervention)
Laryngeal function determined with the Voice-Vibratory Assessment with Laryngeal Imaging (VALI) rating form (Poburka et al., 2017).
Amplitude of vibration: magnitude of lateral movement of the vocal folds. This is a visual-perceptual evaluation based on the video samples of the strobovideolaryngoscopy. Raters score the magnitude of lateral movement of the vocal folds based on the graphic of the VALI form ranging from 0 to 10, this number is then multiplied by 10 to obtain a percentage. Lower percentages mean a smaller amplitude of vibration, higher percentages mean a larger amplitude of vibration.
Time frame: baseline (before the intervention)
Laryngeal function determined with the VALI form (Poburka et al, 2017).
Anteroposterior supraglottic compression: constriction of the supraglottic structures in the anteroposterior dimension. This is a visual-perceptual evaluation based on the video samples of the strobovideolaryngoscopy. Raters score the supraglottic compression based on the graphic of the VALI form on a scale ranging from 0 to 5 (with the aid of concentric circles). The higher the number, the more supraglottic compression. More supraglottic compression is often seen as a negative outcome, however it might be a beneficial effect seen in SOVT phonation studied here.
Time frame: baseline (before the intervention), 1 month (immediately after the intervention), 1 month follow-up, 3 months follow-up
DSI: A higher index indicates a better voice quality. The index ranges from -5 to +5 for severely dysphonic to normal voices. A more negative index indicates a worse voice quality. Values > +5 are possible in subjects with excellent vocal capacities. A DSI = +1.6 is the threshold separating normophonic from dysphonic persons.
Time frame: baseline (before the intervention), 1 month (immediately after the intervention), 1 month follow-up, 3 months follow-up
A lower AVQI indicates a better voice quality. The index ranges from 0 to 10 for normal to severely dysphonic voices. An AVQI of 2.95 is the threshold separating normophonic from dysphonic persons.
Time frame: baseline (before the intervention), 1 month (immediately after the intervention), 1 month follow-up, 3 months follow-up
VHI: A lower index indicates less impact of the voice impairment on the quality of life. The VHI ranges from 0 to 120.
Time frame: baseline (before the intervention), 1 month (immediately after the intervention), 1 month follow-up, 3 months follow-up
VTDS: A lower index indicates less discomfort in the vocal tract. The index ranges from 0 to 96.
Time frame: baseline (before the intervention), 1 month (immediately after the intervention), 1 month follow-up, 3 months follow-up
VFI: A lower index indicates less vocal fatigue. The index ranges from 0 to 76.
University Ghent
Other
Voice Therapy With a Semi-occluded Vocal Tract: From Current Challenges to Next Level Efficacy Studies
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05158166
Adductor Spasmodic Dysphonia, Dysphonia
San Francisco, California, United States
View Trial DetailsNCT04584658
COVID-19, Coronaviridae Infections
Cambridge, United Kingdom
View Trial DetailsNCT03576365
Dysphonia, Functional Dysphonia
Maple Grove, Minnesota, United States
View Trial DetailsNCT00235053
Asthma, Bacterial Infections and Mycoses
San Diego, California, United States
View Trial Details